These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 17931949
1. [Preliminary results for EORTC trial 22911: radical prostatectomy followed by postoperative radiotherapy in prostate cancers with a high risk of progression]. Bolla M, Van Poppel H, Collette L, au nom des groupes génito-urinaire et radiothérapie de l'EORTC. Cancer Radiother; 2007 Nov; 11(6-7):363-9. PubMed ID: 17931949 [Abstract] [Full Text] [Related]
3. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M, European Organization for Research and Treatment of Cancer. Lancet; 2007 Nov; 366(9485):572-8. PubMed ID: 16099293 [Abstract] [Full Text] [Related]
4. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951 [Abstract] [Full Text] [Related]
5. Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Piérart M, European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genito-urinary Groups. Eur J Cancer; 2005 Nov; 41(17):2662-72. PubMed ID: 16223581 [Abstract] [Full Text] [Related]
6. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. Syndikus I, Pickles T, Kostashuk E, Sullivan LD. J Urol; 1996 Jun; 155(6):1983-6. PubMed ID: 8618303 [Abstract] [Full Text] [Related]
7. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L, Bosset JF, Kurth KH, Schröder FH, Collette L, EORTC 22911. J Clin Oncol; 2007 Sep 20; 25(27):4178-86. PubMed ID: 17878474 [Abstract] [Full Text] [Related]
8. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Cozzarini C, Montorsi F, Fiorino C, Alongi F, Bolognesi A, Da Pozzo LF, Guazzoni G, Freschi M, Roscigno M, Scattoni V, Rigatti P, Di Muzio N. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):966-74. PubMed ID: 19619960 [Abstract] [Full Text] [Related]
10. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Strahlenther Onkol; 2005 Jan 15; 181(1):35-41. PubMed ID: 15660191 [Abstract] [Full Text] [Related]
11. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T, Japanese Study Group for Locally Advanced Prostate Cancer. Jpn J Clin Oncol; 2006 Dec 15; 36(12):789-93. PubMed ID: 17082219 [Abstract] [Full Text] [Related]
12. Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard? Ganswindt U, Stenzl A, Bamberg M, Belka C. Eur Urol; 2008 Sep 15; 54(3):528-42. PubMed ID: 18602742 [Abstract] [Full Text] [Related]
13. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. BJU Int; 2008 Jan 15; 101(2):170-4. PubMed ID: 18173824 [Abstract] [Full Text] [Related]
14. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. Teh BS, Bastasch MD, Mai WY, Kattan MW, Butler EB, Kadmon D. J Urol; 2006 Jun 15; 175(6):2097-101; discussion 2101-2. PubMed ID: 16697811 [Abstract] [Full Text] [Related]
15. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539 [Abstract] [Full Text] [Related]
17. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI. J Urol; 2007 Oct 15; 178(4 Pt 1):1306-10. PubMed ID: 17698141 [Abstract] [Full Text] [Related]
18. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ. J Urol; 2008 Aug 15; 180(2):571-6; discussion 576. PubMed ID: 18554662 [Abstract] [Full Text] [Related]
19. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. Smith JA, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, Cookson MS. J Urol; 2007 Dec 15; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849 [Abstract] [Full Text] [Related]
20. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. King CR, Spiotto MT. Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):23-7. PubMed ID: 18207668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]